Crinetics Pharmaceuticals reported revenue of $25.12M and net income of -$122.61M for the quarter ended Jun 2026. This income statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 38.62M | 38.44M | 47.80M | 53.72M | 53.80M | 53.88M | 53.99M | 54.68M | 66.71M | 68.17M | 78.54M | 79.32M | 80.84M | 92.93M | 93.53M | 94.13M | 94.55M | 95.58M | 105.31M | 105.81M | |||||||||||||||||
| Revenue & cost | |||||||||||||||||||||||||||||||||||||
| Revenue | 1.08M | 3.13M | 0.44M | 0.46M | 0.71M | 2.68M | 0.99M | 0.35M | 0.64M | 0.40M | 0.36M | 1.03M | 0.14M | 6.16M | 10.73M | 25.12M | |||||||||||||||||||||
| Gross Profit | 0.36M | 1.03M | 10.53M | 24.96M | |||||||||||||||||||||||||||||||||
| Operating items | |||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 21.58M | 24.60M | 28.25M | 32.99M | 31.99M | 36.99M | 38.47M | 40.64M | 43.84M | 45.58M | 53.34M | 58.34M | 61.91M | 66.57M | 76.24M | 80.30M | 90.46M | 85.05M | 100.08M | 99.85M | |||||||||||||||||
| Selling, General & AdministrativeSG&A | 6.23M | 7.36M | 8.71M | 10.49M | 11.93M | 11.27M | 12.19M | 13.34M | 15.48M | 17.08M | 20.83M | 24.84M | 25.89M | 28.18M | 35.53M | 49.84M | 52.27M | 53.70M | 50.83M | 57.57M | |||||||||||||||||
| Other Operating ExpensesOther Opex | 1.08M | 0.20M | 0.15M | ||||||||||||||||||||||||||||||||||
| Operating ExpensesOpex | 27.81M | 31.97M | 36.96M | 43.48M | 43.91M | 48.27M | 50.66M | 53.98M | 59.32M | 62.66M | 74.17M | 83.18M | 87.80M | 94.75M | 111.77M | 130.14M | 142.73M | 139.83M | 151.11M | 157.58M | |||||||||||||||||
| Operating IncomeOp. Inc | -27.81M | -30.89M | -33.83M | -43.05M | -43.45M | -47.56M | -47.98M | -52.99M | -58.98M | -62.66M | -73.53M | -82.78M | -87.80M | -94.75M | -111.41M | -129.11M | -142.59M | -133.67M | -140.38M | -132.46M | |||||||||||||||||
| EBIT | -27.81M | -30.89M | -33.83M | -43.05M | -43.45M | -47.56M | -47.98M | -52.99M | -58.98M | -62.66M | -73.53M | -82.78M | -87.80M | -94.75M | -111.41M | -129.11M | -142.59M | -133.67M | -140.38M | -132.46M | |||||||||||||||||
| Non-operating items | |||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | |||||||||||||||||||||||||||||||||||||
| Non Operating Investment Income | -1.00M | ||||||||||||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | -0.48M | -1.81M | -1.43M | 1.50M | 8.95M | 2.04M | 2.11M | 2.57M | 6.72M | 7.32M | 8.74M | 11.01M | 14.37M | 14.83M | 13.46M | 12.54M | 11.16M | 12.66M | 12.03M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.04M | -0.22M | -0.20M | 0.02M | -0.05M | -0.12M | -0.13M | -0.42M | |||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | -0.07M | 0.01M | 0.21M | 0.67M | 1.53M | 2.56M | 1.98M | 2.02M | 2.52M | 6.76M | 7.07M | 8.73M | 10.97M | 14.15M | 14.63M | 13.47M | 12.49M | 11.03M | 12.53M | 11.60M | |||||||||||||||||
| Net income details | |||||||||||||||||||||||||||||||||||||
| EBT | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Profit After TaxPAT | -27.87M | -31.16M | -36.44M | -43.80M | -43.32M | -43.91M | -45.99M | -50.98M | -57.46M | -60.10M | -67.76M | -74.39M | -76.83M | -80.61M | -96.77M | -116.02M | -130.09M | -122.81M | -130.96M | -122.61M | |||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Net Income towards Common StockholdersNet Income | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 0.73 | -4.80 | 0.70 | 0.81 | 0.78 | 0.87 | 0.85 | 0.94 | 0.99 | -6.25 | 0.92 | 0.94 | -0.96 | -1.00 | 1.04 | 1.23 | -1.38 | -1.30 | -1.23 | -1.14 | |||||||||||||||||
| EPS (Diluted) | 0.73 | -4.80 | 0.70 | 0.81 | 0.78 | 0.87 | 0.85 | 0.94 | 0.99 | -6.25 | 0.92 | 0.94 | -0.96 | -1.00 | 1.04 | 1.23 | -1.38 | -1.30 | -1.23 | -1.14 | |||||||||||||||||
| Shares Outstanding | 38.31M | 38.44M | 47.71M | 52.52M | 53.77M | 51.98M | 53.91M | 54.27M | 56.81M | 58.07M | 72.29M | 79.01M | 80.09M | 80.78M | 93.10M | 93.79M | 94.22M | 94.06M | 104.10M | 105.56M | |||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 38.31M | 38.44M | 47.71M | 52.52M | 53.77M | 51.98M | 53.91M | 54.27M | 56.81M | 58.07M | 72.29M | 79.01M | 80.09M | 80.78M | 93.10M | 93.79M | 94.22M | 94.06M | 104.10M | 105.56M | |||||||||||||||||
| EBITDA | -27.81M | -30.89M | -33.83M | -43.05M | -43.45M | -47.56M | -47.98M | -52.99M | -58.98M | -62.66M | -73.53M | -82.78M | -87.80M | -94.75M | -111.41M | -129.11M | -142.59M | -133.67M | -140.38M | -132.46M | |||||||||||||||||
| Interest ExpensesInt Expense |